Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Omeros Corp. (NASDAQ: OMER).

Full DD Report for OMER

You must become a subscriber to view this report.


Recent News from (NASDAQ: OMER)

Midday Gainers / Losers (05/16/2018)
Gainers: IHT +50% . BLNK +36% . EBIO +21% . GEMP +18% . VNET +18% . FSI +16% . ABAX +16% . BBOX +13% . ASNA +14% . NSPR +14% . More news on: Innsuites Hospitality Trust, Blink Charging Co., Eleven Biotherapeutics, Inc., Stocks on the move, , Read more ....
Source: SeekingAlpha
Date: May, 16 2018 13:00
Rounds Report: Omeros Rallied Robustly While Stellar FDA Due Diligence To Help Orphan Disease Innovators
Those who keep learning will keep rising in life. - Charlie Munger Trading Analytics Welcome to the edition of Integrated BioSci Rounds Report for May 14, 2018. As usual, we’ll elucidate notable trading analytics for the day, recent insider transactions, and interesting market d...
Source: SeekingAlpha
Date: May, 16 2018 06:38
Lucky Seven: Immune Design Takes Off, Institutions Place Bets On Viking Therapeutics
Lucky Seven The Lucky Seven is a swing-trading biotechnology portfolio of seven stocks listed in a way to reflect top picks and risk tolerance. The first three picks are the top picks (in no particular order). Risks are increased the further away a stock sits from #4 (the least risky stoc...
Source: SeekingAlpha
Date: May, 16 2018 03:55
Your Daily Pharma Scoop: Omeros Up On Update, Synergy Sales, President's Healthcare Plans
Analysis focus: OMER Omeros (NASDAQ: OMER ) is moving towards a rolling BLA submission for OMS721. On this good news, and despite tepid Q1 results, investors are becoming increasingly bullish the stock, as seen by its sudden 23% spike on the news of the BLA submission. OMS721 is in tri...
Source: SeekingAlpha
Date: May, 14 2018 10:00
Lucky Seven: Achaogen Likely To Bounce Back
The biotechnology sector ( XBI ) felt good about itself last week. As a result, many of the promising, up-and-coming biotechnology companies saw investors throwing their cash back at them in hopes of profitable returns. We anticipate the trend will continue, at least for a short time: C...
Source: SeekingAlpha
Date: May, 14 2018 08:19
Today's Research Reports on Trending Tickers: Omeros and bluebird bio
NEW YORK, NY / ACCESSWIRE / May 14, 2018 / U.S. markets were mixed on Friday, with the Dow Jones logging its 7th consecutive daily gain, the longest streak since 2017. Comments from President Trump on changing health-care policy dragged markets to intraday losses before bouncing back. The D...
Source: ACCESSWIRE IA
Date: May, 14 2018 08:00
Rounds Report: Omeros Rallied While Stellar FDA Due Diligence To Help Atara Biotherapeutics
You need a different checklist and different mental models for different companies. I can never make it easy by saying, ‘Here are three things.’ You have to derive it yourself to ingrain it in your head for the rest of your life. - Charlie Munger Trading Analytics Welcome...
Source: SeekingAlpha
Date: May, 13 2018 03:46
Lucky Seven: Omeros Pops, Exelixis Drops On Phase 3 Flop
Thursday and Friday were eventful days for the Lucky Seven and for biotechnology stocks, in general. It requires portfolio reassessment. First, Some Guidelines Before we begin, I'd like to discuss some additional key points to the purpose of the Lucky Seven portfolio: The goal, for all...
Source: SeekingAlpha
Date: May, 12 2018 00:23
Omeros up 23% on preparations for BLA for OMS721
Ignoring tepid Q1 results , investors are moving into Omeros ( OMER +23.4% ) after the company announced initial preparations for a U.S. marketing application for OMS721 for HSCT-TMA. More news on: Omeros Corporation, Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: May, 11 2018 13:36
Midday Gainers / Losers (05/11/2018)
Gainers:  ANFI +83% . HEAR +48% . TTD +40% . ARCB +28% . WOW +28% . OMER +24% . MOSY +24% . BOXL +20% . BLNK +20% . EOLS +17% . More news on: Amira Nature Foods, Turtle Beach Corporation, The Trade Desk, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: May, 11 2018 12:41

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-2320.6519.7920.9219.67816,333
2018-05-2221.0420.7921.9820.60845,004
2018-05-2120.1420.7921.0820.0518729,809
2018-05-1820.3520.1221.1019.93933,271
2018-05-1719.9020.2621.8019.291,679,416

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-2485,803152,30956.3348Short
2018-05-23154,749243,45163.5647Short
2018-05-22228,026379,63560.0645Short
2018-05-2171,380218,19132.7145Cover
2018-05-18110,406278,69839.6149Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OMER.


About Omeros Corp. (NASDAQ: OMER)

Logo for Omeros Corp. (NASDAQ: OMER)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $960,408,102 - 05/11/2018
  • Issue and Outstanding: 48,285,978 - 02/26/2018

 


Recent Filings from (NASDAQ: OMER)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 01 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 01 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 09 2018

 

 


Daily Technical Chart for (NASDAQ: OMER)

Daily Technical Chart for (NASDAQ: OMER)


Stay tuned for daily updates and more on (NASDAQ: OMER)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: OMER)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OMER is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of OMER and does not buy, sell, or trade any shares of OMER. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/